id
stringlengths
7
8
tokens
sequence
ner_tags
sequence
texts
stringlengths
0
8.69k
9841584
[ "Decision", "analysis", "model.", "Lifetime", "risk", "for", "colorectal", "cancer,", "efficacy", "of", "surveillance", "and", "colectomy,", "stage-specific", "colorectal", "cancer", "mortality,", "and", "quality", "of", "life", "were", "included", "in", "the", "model." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Decision analysis model. Lifetime risk for colorectal cancer, efficacy of surveillance and colectomy, stage-specific colorectal cancer mortality, and quality of life were included in the model.
26925673
[ "The", "results", "of", "the", "present", "study", "revealed", "that", "EA", "exerts", "anti-proliferative", "and", "dose-dependent", "pro-apoptotic", "effects.", "Cytostatic", "and", "cytotoxic", "effects", "were", "also", "observed.", "p-", "Akt", "Ser473", ")", "in", "the", "presence", "and", "absence", "of", "different", "concentrations", "of", "EA.", "Cell", "proliferation", "was", "also", "assessed", "in", "cells", "transfected", "with", "different", "concentrations", "of", "K-Ras", "siRNA", "or", "incubated", "with", "ellagic", "acid", "following", "transfection." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
The results of the present study revealed that EA exerts anti-proliferative and dose-dependent pro-apoptotic effects. Cytostatic and cytotoxic effects were also observed. p- Akt Ser473 ) in the presence and absence of different concentrations of EA. Cell proliferation was also assessed in cells transfected with different concentrations of K-Ras siRNA or incubated with ellagic acid following transfection.
19706845
[ "A", "hospital-based", "case-control", "study", "of", "440", "CRC", "patients", "and", "800", "cancer-free", "controls", "was", "conducted.", "Personal", "information", "was", "collected", "by", "a", "Semi-Quantitative", "Food", "Frequency", "Questionnaire.", "The", "tag", "SNPs", " ", "were", "screened", "in", "the", "HapMap", "with", "Haploview", "by", "setting", "the", "minor", "allele", "frequency", "at", "0.03", "with", "the", "highest", "score", "of", "r(2)", "form", "each", "block.", "Genotypes", "were", "identified", "by", "using", "the", "SNPLex", "System.", "Both", "crude", "and", "adjusted", "odds", "ratio", "(OR)", "and", "95%", "confidence", "interval", "(CI)", "were", "used", "to", "evaluate", "the", "risk", "of", "each", "SNP", "CYP2E1", ",", "and", "to", "evaluate", "the", "association", "between", "these", "tagSNPs", "and", "colorectal", "cancer", "(CRC)", "in", "a", "southwestern", "Chinese", "population." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
A hospital-based case-control study of 440 CRC patients and 800 cancer-free controls was conducted. Personal information was collected by a Semi-Quantitative Food Frequency Questionnaire. The tag SNPs were screened in the HapMap with Haploview by setting the minor allele frequency at 0.03 with the highest score of r(2) form each block. Genotypes were identified by using the SNPLex System. Both crude and adjusted odds ratio (OR) and 95% confidence interval (CI) were used to evaluate the risk of each SNP CYP2E1 , and to evaluate the association between these tagSNPs and colorectal cancer (CRC) in a southwestern Chinese population.
26416897
[ "##", "PATIENTS", "AND", "METHODS" ]
[ 0, 0, 0, 0 ]
## PATIENTS AND METHODS
20725929
[]
[]
26302849
[ "Our", "results", "provide", "evidence", "that", "variants", "of", "PRLHR", "HSPA12A", "PRLHR", " ", "and", "HSPA12A", "and", "risk", "of", "gastric", "and", "colorectal", "cancer", "in", "the", "Chinese", "Han", "population.", "\n\n\n", "##", "BACKGROUND" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Our results provide evidence that variants of PRLHR HSPA12A PRLHR and HSPA12A and risk of gastric and colorectal cancer in the Chinese Han population. ## BACKGROUND
9731891
[ "##", "METHODS" ]
[ 0, 0 ]
## METHODS
16924054
[ "Muir-Torre", "syndrome", "(MTS)", "is", "an", "autosomal", "dominant", "genodermatosis", "characterized", "by", "the", "association", "of", "at", "least", "1", "cutaneous", "sebaceous", "tumor", "and", "1", "internal", "malignancy,", "often", "arising", "in", "the", "gastrointestinal", "tract.", "It", "is", "secondary", "to", "germline", "mutations", "in", "DNA", "mismatch", "repair", "genes,", "mainly", "MLH-1", "and", "MSH-2." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Muir-Torre syndrome (MTS) is an autosomal dominant genodermatosis characterized by the association of at least 1 cutaneous sebaceous tumor and 1 internal malignancy, often arising in the gastrointestinal tract. It is secondary to germline mutations in DNA mismatch repair genes, mainly MLH-1 and MSH-2.
22895193
[ "Recurrent", "R-spondin", "fusions", "in", "colon", "cancer." ]
[ 0, 0, 0, 0, 0, 0 ]
Recurrent R-spondin fusions in colon cancer.
9841584
[ "Decision", "analysis", "model.", "Lifetime", "risk", "for", "colorectal", "cancer,", "efficacy", "of", "surveillance", "and", "colectomy,", "stage-specific", "colorectal", "cancer", "mortality,", "and", "quality", "of", "life", "were", "included", "in", "the", "model." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Decision analysis model. Lifetime risk for colorectal cancer, efficacy of surveillance and colectomy, stage-specific colorectal cancer mortality, and quality of life were included in the model.
25029911
[ "As", "a", "novel", "candidate", "metastasis", "suppressor", "gene,", "Nasopharyngeal", "carcinoma-associated", "gene", "6", "(NGX6)", "is", "involved", "in", "cellular", "growth,", "cell", "cycle", "progression", "and", "tumor", "angiogenesis.", "Previous", "studies", "have", "shown", "that", "NGX6", "gene", "is", "down-regulated", "in", "colorectal", "cancer", "(CRC).", "However,", "little", "is", "known", "about", "its", "transcriptional", "regulation." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
As a novel candidate metastasis suppressor gene, Nasopharyngeal carcinoma-associated gene 6 (NGX6) is involved in cellular growth, cell cycle progression and tumor angiogenesis. Previous studies have shown that NGX6 gene is down-regulated in colorectal cancer (CRC). However, little is known about its transcriptional regulation.
19140394
[]
[]
14734469
[ "We", "observed", "a", "strong", "correlation", "of", "BRAF", "mutation", "with", "hMLH1", "promoter", "methylation.", "BRAF", "mutations", "were", "present", "in", "13", "of", "15", "(87%)", "of", "the", "colorectal", "cell", "lines", "and", "cancers", "with", "methylated", "hMLH1,", "whereas", "only", "4", "of", "91", "(4%)", "of", "the", "cell", "lines", "and", "cancers", "with", "unmethylated", "hMLH1", "carried", "the", "mutations", "(P", "<", "0.00001).", "Sixteen", "of", "17", "mutations", "were", "at", "residue", "599", "(V599E).", "A", "BRAF", "mutation", "BRAF", " ", "mutations", "in", "sporadic", "colorectal", "cancer", "with", "microsatellite", "instability", "(MSI)", "are", "more", "frequently", "detected", "than", "those", "in", "microsatellite", "stable", "cancer.", "In", "this", "study,", "we", "sought", "to", "compare", "the", "frequencies", "of", "BRAF", "serine/threonine", "kinase", " ", "and", "plays", "an", "important", "role", "in", "the", "mitogen-activated", "protein", "kinase", "signaling", "pathway.", "BRAF", "mutations", "in", "sporadic", "colorectal", "cancer", "with", "microsatellite", "instability", "(MSI)", "are", "more", "frequently", "detected", "than", "those", "in", "microsatellite", "stable", "cancer.", "In", "this", "study,", "we", "sought", "to", "compare", "the", "frequencies", "of", "BRAF", "mutations", "in", "sporadic", "colorectal", "cancer", "with", "MSI", "with", "those", "in", "hereditary", "nonpolyposis", "colorectal", "cancer", "(HNPCC)." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
We observed a strong correlation of BRAF mutation with hMLH1 promoter methylation. BRAF mutations were present in 13 of 15 (87%) of the colorectal cell lines and cancers with methylated hMLH1, whereas only 4 of 91 (4%) of the cell lines and cancers with unmethylated hMLH1 carried the mutations (P < 0.00001). Sixteen of 17 mutations were at residue 599 (V599E). A BRAF mutation BRAF mutations in sporadic colorectal cancer with microsatellite instability (MSI) are more frequently detected than those in microsatellite stable cancer. In this study, we sought to compare the frequencies of BRAF serine/threonine kinase and plays an important role in the mitogen-activated protein kinase signaling pathway. BRAF mutations in sporadic colorectal cancer with microsatellite instability (MSI) are more frequently detected than those in microsatellite stable cancer. In this study, we sought to compare the frequencies of BRAF mutations in sporadic colorectal cancer with MSI with those in hereditary nonpolyposis colorectal cancer (HNPCC).
26302849
[ "Gastric", "and", "colorectal", "cancers", "have", "a", "major", "impact", "on", "public", "health,", "and", "are", "the", "most", "common", "malignant", "tumors", "in", "China.", "The", "aim", "of", "this", "research", "was", "to", "study", "whether", "polymorphisms", "of", "CHCHD3P1-HSP90AB7P,", "GRID1,", "HSPA12A,", "PRLHR,", "SBF2,", "POLD3", "and", "C11orf93-C11orf92", "genes", "are", "associated", "with", "the", "risk", "of", "gastric", "and", "colorectal", "cancers", "in", "the", "Chinese", "Han", "population." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Gastric and colorectal cancers have a major impact on public health, and are the most common malignant tumors in China. The aim of this research was to study whether polymorphisms of CHCHD3P1-HSP90AB7P, GRID1, HSPA12A, PRLHR, SBF2, POLD3 and C11orf93-C11orf92 genes are associated with the risk of gastric and colorectal cancers in the Chinese Han population.
22810479
[ "##", "DATA", "SOURCES" ]
[ 0, 0, 0 ]
## DATA SOURCES
14734469
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
26416897
[ "##", "PATIENTS", "AND", "METHODS" ]
[ 0, 0, 0, 0 ]
## PATIENTS AND METHODS
12534642
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
25374237
[ "Colon", "cancer", "is", "one", "of", "the", "most", "common", "cancers", "worldwide.", "Apoptosis", "is", "a", "necessary", "physiological", "process", "for", "cell", "elimination", "which", "is", "very", "important", "both", "cellular", "homeostasis", "and", "cell", "proliferation", "and", "differantiation.", "Dysregulation", "can", "lead", "to", "uncontrolled", "cell", "growth", "and", "tumor", "development.", "Survivin,", "a", "member", "of", "the", "IAP", "family,", "plays", "a", "key", "role", "in", "promotion", "of", "cell", "proliferation", "as", "well", "as", "inhibition", "of", "apoptosis", "in", "cancer", "cells.", "The", "aim", "of", "this", "study", "was", "to", "investigate", "whether", "specific", "genetic", "polymorphisms", "of", "survivin", "could", "be", "associated", "with", "colon", "cancer", "development", "and", "progression", "in", "a", "Turkish", "population.", "Our", "study", "is", "the", "first", "to", "our", "knowledge", "to", "investigate", "the", "relationship", "between", "colon", "cancer", "risk", "and", "survivin", "gene", "polymorphisms." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Colon cancer is one of the most common cancers worldwide. Apoptosis is a necessary physiological process for cell elimination which is very important both cellular homeostasis and cell proliferation and differantiation. Dysregulation can lead to uncontrolled cell growth and tumor development. Survivin, a member of the IAP family, plays a key role in promotion of cell proliferation as well as inhibition of apoptosis in cancer cells. The aim of this study was to investigate whether specific genetic polymorphisms of survivin could be associated with colon cancer development and progression in a Turkish population. Our study is the first to our knowledge to investigate the relationship between colon cancer risk and survivin gene polymorphisms.
24196785
[]
[]
20646601
[ "Detection", "of", "K-ras", "gene", "status", "in", "colorectal", "cancer", "will", "help", "to", "select", "the", "patients", "likely", "to", "benefit", "from", "the", "monoclonal", "antibody", "therapy", "of", "targeting", "epidermal", "growth", "factor", "receptor." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Detection of K-ras gene status in colorectal cancer will help to select the patients likely to benefit from the monoclonal antibody therapy of targeting epidermal growth factor receptor.
23497483
[ "We", "found", "a", "higher", "mutation", " ", "rate", "of", "somatic", "variants", " ", "in", "tumor", "tissues", "in", "comparison", "with", "normal", "tissues,", "but", "no", "trend", "was", "observed", "for", "mutation", " ", "properties.", "By", "applying", "a", "series", "of", "stringent", "filters,", "we", "identified", "418", "genes", "with", "tumor", "specific", "disruptive", "somatic", "variants", ".", "Of", "these", "genes,", "three", "genes", "in", "mucin", "protein", "family", "(MUC2,", "MUC4,", "and", "MU12)", "are", "of", "particular", "interests.", "It", "has", "been", "reported", "that", "the", "expression", "of", "mucin", "proteins", "was", "correlated", "with", "the", "progression", "of", "colorectal", "cancer", "therefore", "somatic", "variants", " ", "within", "those", "genes", "can", "interrupt", "their", "normal", "expression", "and", "thus", "contribute", "to", "the", "tumorigenesis." ]
[ 0, 0, 0, 0, 9, 0, 0, 0, 0, 9, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 9, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 9, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 9, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
We found a higher mutation rate of somatic variants in tumor tissues in comparison with normal tissues, but no trend was observed for mutation properties. By applying a series of stringent filters, we identified 418 genes with tumor specific disruptive somatic variants . Of these genes, three genes in mucin protein family (MUC2, MUC4, and MU12) are of particular interests. It has been reported that the expression of mucin proteins was correlated with the progression of colorectal cancer therefore somatic variants within those genes can interrupt their normal expression and thus contribute to the tumorigenesis.
26925673
[ "To", "evaluate", "the", "impact", "of", "cellular", "genetic", "make-", "up", "of", "two", "colon", "cancer", "cell", "lines", "with", "different", "genetic", "backgrounds,", "HCT-116", "(K-Ras-/p53+)", "and", "Caco-2", "(K-Ras+/", "p53-),", "on", "response", "to", "potential", "anti-tumour", "effects", "of", "EA.", "In", "addition,", "the", "influence", "of", "K-Ras", "silencing", "in", "HCT-", "116", "cells", "was", "investigated." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
To evaluate the impact of cellular genetic make- up of two colon cancer cell lines with different genetic backgrounds, HCT-116 (K-Ras-/p53+) and Caco-2 (K-Ras+/ p53-), on response to potential anti-tumour effects of EA. In addition, the influence of K-Ras silencing in HCT- 116 cells was investigated.
8431846
[ "Multiple", "polyps", "of", "esophagus,", "stomach,", "colon,", "and", "rectum", "accompanying", "rectal", "cancer", "in", "a", "patient", "with", "constitutional", "chromosomal", "inversion.", "\n\n\n", "##", "BACKGROUND" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Multiple polyps of esophagus, stomach, colon, and rectum accompanying rectal cancer in a patient with constitutional chromosomal inversion. ## BACKGROUND
16924054
[ "##", "OBSERVATIONS" ]
[ 0, 0 ]
## OBSERVATIONS
9731891
[ "One", "hundred", "and", "twenty-five", "cases", "of", "sporadic", "colon", "carcinoma", "(50", "in", "the", "right", "colon", "and", "75", "in", "the", "left", "colon", "in", "patients", "with", "no", "family", "history", "of", "colon", "carcinoma)", "were", "studied.", "Status", "of", "the", "p53", "gene", "was", "assessed", "by", "polymerase", "chain", "reaction", "(PCR),", "single", "strand", "conformation", "polymorphism,", "and", "sequencing", "at", "exons", "5-8.", "Microsatellite", "instability", "was", "analyzed", "with", "five", "microsatellite", "markers", "at", "chromosome", "18.", "The", "mismatch", "repair", "genes", "hMLH1", "and", "hMSH2", "were", "studied", "in", "tumors", "found", "to", "have", "microsatellite", "instability", "by", "PCR", "and", "sequencing." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
One hundred and twenty-five cases of sporadic colon carcinoma (50 in the right colon and 75 in the left colon in patients with no family history of colon carcinoma) were studied. Status of the p53 gene was assessed by polymerase chain reaction (PCR), single strand conformation polymorphism, and sequencing at exons 5-8. Microsatellite instability was analyzed with five microsatellite markers at chromosome 18. The mismatch repair genes hMLH1 and hMSH2 were studied in tumors found to have microsatellite instability by PCR and sequencing.
9439149
[ "Microsatellite", "instability", "in", "Korean", "patients", "with", "gastric", "adenocarcinoma.", "\n\n\n", "##", "OBJECTIVES" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Microsatellite instability in Korean patients with gastric adenocarcinoma. ## OBJECTIVES
9841584
[ "All", "risk-reduction", "strategies", "led", "to", "large", "gains", "in", "life", "expectancy", "for", "carriers", "of", "a", "mutation", "for", "hereditary", "nonpolyposis", "colorectal", "cancer,", "with", "benefits", "ranging", "from", "13.5", "years", "for", "surveillance", "to", "15.6", "years", "for", "prophylactic", "proctocolectomy", "at", "25", "years", "of", "age", "compared", "with", "no", "intervention.", "The", "benefits", "of", "colectomy", "compared", "with", "surveillance", "decreased", "with", "increasing", "age", "and", "were", "minimal", "if", "colectomy", "was", "performed", "at", "the", "time", "of", "colorectal", "cancer", "diagnosis.", "When", "health-related", "quality", "of", "life", "was", "considered,", "surveillance", "led", "to", "the", "greatest", "quality-adjusted", "life", "expectancy", "benefit", "(3.1", "years", "compared", "with", "proctocolectomy", "and", "0.3", "years", "compared", "with", "subtotal", "colectomy)." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
All risk-reduction strategies led to large gains in life expectancy for carriers of a mutation for hereditary nonpolyposis colorectal cancer, with benefits ranging from 13.5 years for surveillance to 15.6 years for prophylactic proctocolectomy at 25 years of age compared with no intervention. The benefits of colectomy compared with surveillance decreased with increasing age and were minimal if colectomy was performed at the time of colorectal cancer diagnosis. When health-related quality of life was considered, surveillance led to the greatest quality-adjusted life expectancy benefit (3.1 years compared with proctocolectomy and 0.3 years compared with subtotal colectomy).
9691992
[ "Microsatellite", "instability", "of", "DNA", "samples", "of", "79", "sporadic", "colon", "cancer", "patients", "were", "analyzed.", "These", "samples", "were", "also", "screened", "to", "search", "mutations", "in", "the", "repeat", "sequences", "in", "the", "gene", "for", "the", "type", "II", "receptor", "of", "transforming", "growth", "factor-beta", " ", "(TGF-beta", "RII)", "using", "polymerase", "chain", "reaction", "(PCR),", "electrophoresis", "with", "urea", "gel,", "and", "PCR-single", "strand", "conformation", "polymorphism", "(PCR-SSCP)", "method.", "The", "incidence", "of", "microsatellite", "instability,", "defined", "as", "severe", "replication", "error", "phenotype", "(RER)", "with", "microsatellite", "alterations", "in", "more", "than", "three", "loci,", "was", "6%.", "Deletion", "and", "insertion", "of", "an", "A", "residue", "in", "the", "(A)10", "region,", "which", "cause", "frameshift", "mutation,", "were", "found", "in", "four", "samples", "and", "their", "incidence", "in", "the", "samples", "with", "microsatellite", "instability", "was", "80%.", "A", "novel", "nucleotide", "substitution", "of", "T", "for", "G", "at", "1918,", "which", "causes", "missense", "mutation", "of", "arginine", "to", "leucine", "at", "codon", "528,", "was", "found", "in", "a", "sample", "with", "microsatellite", "instability.", "The", "mutation", "at", "1918", "was", "in", "highly", "conservative", "amino", "acid", "residue." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Microsatellite instability of DNA samples of 79 sporadic colon cancer patients were analyzed. These samples were also screened to search mutations in the repeat sequences in the gene for the type II receptor of transforming growth factor-beta (TGF-beta RII) using polymerase chain reaction (PCR), electrophoresis with urea gel, and PCR-single strand conformation polymorphism (PCR-SSCP) method. The incidence of microsatellite instability, defined as severe replication error phenotype (RER) with microsatellite alterations in more than three loci, was 6%. Deletion and insertion of an A residue in the (A)10 region, which cause frameshift mutation, were found in four samples and their incidence in the samples with microsatellite instability was 80%. A novel nucleotide substitution of T for G at 1918, which causes missense mutation of arginine to leucine at codon 528, was found in a sample with microsatellite instability. The mutation at 1918 was in highly conservative amino acid residue.
22899730
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
12530077
[ "Mucin-1", "is", "expressed", "in", "a", "variety", "of", "colon", "carcinomas", "and", "Muc-1/DF3", "promoters", "have", "been", "utilized", "to", "reduce", "systemic", "toxicity", "through", "specific", "gene", "expression.", "To", "overcome", "weak", "expression,", "which", "is", "much", "lower", "than", "the", "widely", "used", "cytomegalovirus-promoter", "(CMV),", "new", "adenoviral", "vectors", "containing", "a", "binary", "system", "of", "transgene", "amplification", "have", "been", "developed.", "The", "Muc-1/DF3", "promoter", "was", "used", "to", "control", "the", "expression", "of", "a", "Gal4VP16", "fusion", "protein.", "This", "vector", "also", "contained", "Gal4", " ", "binding", "sites", "enabling", "the", "fusion", "protein", "to", "act", "as", "a", "transactivator,", "inducing", "transgene", "expression", "within", "the", "same", "construct.", "Mucin-1", " ", "expression", "was", "analyzed", "in", "a", "variety", "of", "colon", "cancer", "cell", "lines.", "After", "infection", "with", "recombinant", "adenoviruses,", "transgene", "expression", "was", "quantified", "using", "the", "luciferase", "system.", "Integration", "of", "the", "Gal4VP16-binary", "resulted", "in", "an", "up", "to", "250-fold", "increase", "of", "Muc-1/DF3-specific", "gene", "expression.", "In", "mucin-positive", "cell", "lines", "utilizing", "this", "amplified", "Muc-1/DF3", "promoter,", "expression", "was", "up", "to", "590-fold", "higher", "as", "compared", "to", "the", "CMV-promoter.", "Western", "blot", "detected", "the", "presence", "of", "Gal4VP16", "in", "infected", "muc-1", "mucin", "Muc1", "-specific", "gene", "expression", "in", "colon", "cancer", "cells", "utilizing", "a", "binary", "system", "in", "adenoviral", "vectors." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Mucin-1 is expressed in a variety of colon carcinomas and Muc-1/DF3 promoters have been utilized to reduce systemic toxicity through specific gene expression. To overcome weak expression, which is much lower than the widely used cytomegalovirus-promoter (CMV), new adenoviral vectors containing a binary system of transgene amplification have been developed. The Muc-1/DF3 promoter was used to control the expression of a Gal4VP16 fusion protein. This vector also contained Gal4 binding sites enabling the fusion protein to act as a transactivator, inducing transgene expression within the same construct. Mucin-1 expression was analyzed in a variety of colon cancer cell lines. After infection with recombinant adenoviruses, transgene expression was quantified using the luciferase system. Integration of the Gal4VP16-binary resulted in an up to 250-fold increase of Muc-1/DF3-specific gene expression. In mucin-positive cell lines utilizing this amplified Muc-1/DF3 promoter, expression was up to 590-fold higher as compared to the CMV-promoter. Western blot detected the presence of Gal4VP16 in infected muc-1 mucin Muc1 -specific gene expression in colon cancer cells utilizing a binary system in adenoviral vectors.
23012243
[]
[]
17096342
[]
[]
18554281
[ "Hereditary", "non-polyposis", "colorectal", "cancer", "(HNPCC)", "is", "an", "autosomal", "dominant", "condition", "caused", "by", "inactivating", "mutations", " ", "of", "DNA", "mismatch", "repair", "(MMR)", "genes.", "An", "accurate", "estimation", "of", "colorectal", "cancer", "risk", "for", "mutation", "carriers", "is", "essential", "for", "counselling", "and", "rationalizing", "screening", "programmes.", "Families", "were", "referred", "on", "the", "basis", "of", "clinical", "criteria.", "Tumour", "immunohistochemistry", "and", "microsatellite", "testing", "were", "performed.", "Appropriate", "patients", "underwent", "sequencing", "of", "all", "relevant", "exons", "of", "the", "MMR", "genes.", "Proven", "and", "obligate", "mutation", "carriers", "and", "first-degree", "relatives", "(FDRs)", "with", "an", "HNPCC", "spectrum", "cancer", "were", "considered", "mutation", "carriers,", "as", "were", "a", "proportion", "of", "untested,", "unaffected", "FDRs", "based", "on", "the", "proportion", "of", "unaffected", "relatives", "testing", "positive", "in", "each", "age", "group.", "The", "cumulative", "lifetime", "risk", "was", "calculated", "by", "Kaplan-Meier", "analysis.", "Three", "hundred", "and", "forty-one", "colorectal", "cancers", "in", "839", "proven,", "obligate,", "or", "assumed", "mutation", "carriers", "were", "analysed.", "The", "cumulative", "risk", "to", "age", "70", "years", "for", "all", "mutation", "carriers", "combined", "was", "50.4%", "(95%", "CI", "47.8-52.9).", "The", "cumulative", "risk", "in", "males", "was", "54.3%", "(95%", "CI", "50.7-57.8),", "which", "was", "significantly", "higher", "than", "in", "females", "(log", "rank", "p", "=", "0.02)", "who", "had", "a", "risk", "of", "46.3%", "(95%", "CI", "42.8-49.9).", "These", "penetrance", "estimates", "from", "HNPCC", "families", "attending", "high-risk", "clinics", "have", "been", "corrected", "for", "ascertainment", "bias", "and", "are", "appropriate", "risks", "for", "those", "referred", "to", "a", "high-risk", "clinic.", "Current", "colonoscopic", "screening", "guidelines", "are", "appropriate." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant condition caused by inactivating mutations of DNA mismatch repair (MMR) genes. An accurate estimation of colorectal cancer risk for mutation carriers is essential for counselling and rationalizing screening programmes. Families were referred on the basis of clinical criteria. Tumour immunohistochemistry and microsatellite testing were performed. Appropriate patients underwent sequencing of all relevant exons of the MMR genes. Proven and obligate mutation carriers and first-degree relatives (FDRs) with an HNPCC spectrum cancer were considered mutation carriers, as were a proportion of untested, unaffected FDRs based on the proportion of unaffected relatives testing positive in each age group. The cumulative lifetime risk was calculated by Kaplan-Meier analysis. Three hundred and forty-one colorectal cancers in 839 proven, obligate, or assumed mutation carriers were analysed. The cumulative risk to age 70 years for all mutation carriers combined was 50.4% (95% CI 47.8-52.9). The cumulative risk in males was 54.3% (95% CI 50.7-57.8), which was significantly higher than in females (log rank p = 0.02) who had a risk of 46.3% (95% CI 42.8-49.9). These penetrance estimates from HNPCC families attending high-risk clinics have been corrected for ascertainment bias and are appropriate risks for those referred to a high-risk clinic. Current colonoscopic screening guidelines are appropriate.
9609758
[ "Both", "receptors", "were", "overexpressed", "in", "tumors", "compared", "with", "normal", "samples.", "There", "was", "a", "relationship", "between", "the", "abundance", "of", "type", "II", "receptor", "type", "II", "receptor", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 1, 2, 2, 0 ]
Both receptors were overexpressed in tumors compared with normal samples. There was a relationship between the abundance of type II receptor type II receptor .
12534642
[ "From", "genomic", "DNA,", "114", "British", "Caucasians", "(49", "colorectal", "cancer", "cases", "and", "65", "controls)", "were", "genotyped", "for", "the", "CYP1A2", "polymorphisms", "-3858G-->A", "(allele", "CYP1A2*1C),", "-2464T-->delT", "(CYP1A2*1D),", "-740T-->G", "(CYP1A2*1E", "and", "*1G),", "-164A-->C", "(CYP1A2*1F),", "63C-->G", "(CYP1A2*2),", "and", "1545T-->C", "(alleles", "CYP1A2*1B,", "*1G,", "*1H", "and", "*3),", "using", "polymerase", "chain", "reaction-restriction", "fragment", "length", "polymorphism", "assays.", "All", "patients", "and", "controls", "were", "phenotyped", "for", "CYP1A2", "by", "h.p.l.c.", "analysis", "of", "urinary", "caffeine", "metabolites." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
From genomic DNA, 114 British Caucasians (49 colorectal cancer cases and 65 controls) were genotyped for the CYP1A2 polymorphisms -3858G-->A (allele CYP1A2*1C), -2464T-->delT (CYP1A2*1D), -740T-->G (CYP1A2*1E and *1G), -164A-->C (CYP1A2*1F), 63C-->G (CYP1A2*2), and 1545T-->C (alleles CYP1A2*1B, *1G, *1H and *3), using polymerase chain reaction-restriction fragment length polymorphism assays. All patients and controls were phenotyped for CYP1A2 by h.p.l.c. analysis of urinary caffeine metabolites.
23096495
[]
[]
14734469
[ "We", "observed", "a", "strong", "correlation", "of", "BRAF", "mutation", "with", "hMLH1", "promoter", "methylation", ".", "BRAF", "mutations", "were", "present", "in", "13", "of", "15", "(87%)", "of", "the", "colorectal", "cell", "lines", "and", "cancers", "with", "methylated", "hMLH1,", "whereas", "only", "4", "of", "91", "(4%)", "of", "the", "cell", "lines", "and", "cancers", "with", "unmethylated", "hMLH1", "carried", "the", "mutations", "(P", "<", "0.00001).", "Sixteen", "of", "17", "mutations", "were", "at", "residue", "599", "(V599E).", "A", "BRAF", "mutation", "was", "also", "identified", "at", "residue", "463", "(G463V)", "in", "one", "cell", "line.", "In", "addition,", "BRAF", "mutations", "were", "not", "found", "in", "any", "cancers", "or", "cell", "lines", "with", "K-ras", " ", "mutations.", "In", "20", "MSI+", "cancers", "from", "HNPCC", "patients,", "however,", "BRAF", "mutations", "were", "not", "detectable,", "including", "a", "subset", "of", "9", "tumors", "with", "negative", "hMLH1", "immunostaining", "and", "methylated", "hMLH1", "mutations", " ", "were", "present", "in", "13", "of", "15", "(87%)", "of", "the", "colorectal", "cell", "lines", "and", "cancers", "with", "methylated", "hMLH1,", "whereas", "only", "4", "of", "91", "(4%)", "of", "the", "cell", "lines", "and", "cancers", "with", "unmethylated", "hMLH1", "carried", "the", "mutations", "(P", "<", "0.00001).", "Sixteen", "of", "17", "mutations", "were", "at", "residue", "599", "(V599E).", "A", "BRAF", "mutation", "was", "also", "identified", "at", "residue", "463", "(G463V)", "in", "one", "cell", "line.", "In", "addition,", "BRAF", "mutations", "were", "not", "found", "in", "any", "cancers", "or", "cell", "lines", "with", "K-ras", "mutations.", "In", "20", "MSI+", "cancers", "from", "HNPCC", "patients,", "however,", "BRAF", "mutations", "were", "not", "detectable,", "including", "a", "subset", "of", "9", "tumors", "with", "negative", "hMLH1", "immunostaining", "and", "methylated", "hMLH1." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
We observed a strong correlation of BRAF mutation with hMLH1 promoter methylation . BRAF mutations were present in 13 of 15 (87%) of the colorectal cell lines and cancers with methylated hMLH1, whereas only 4 of 91 (4%) of the cell lines and cancers with unmethylated hMLH1 carried the mutations (P < 0.00001). Sixteen of 17 mutations were at residue 599 (V599E). A BRAF mutation was also identified at residue 463 (G463V) in one cell line. In addition, BRAF mutations were not found in any cancers or cell lines with K-ras mutations. In 20 MSI+ cancers from HNPCC patients, however, BRAF mutations were not detectable, including a subset of 9 tumors with negative hMLH1 immunostaining and methylated hMLH1 mutations were present in 13 of 15 (87%) of the colorectal cell lines and cancers with methylated hMLH1, whereas only 4 of 91 (4%) of the cell lines and cancers with unmethylated hMLH1 carried the mutations (P < 0.00001). Sixteen of 17 mutations were at residue 599 (V599E). A BRAF mutation was also identified at residue 463 (G463V) in one cell line. In addition, BRAF mutations were not found in any cancers or cell lines with K-ras mutations. In 20 MSI+ cancers from HNPCC patients, however, BRAF mutations were not detectable, including a subset of 9 tumors with negative hMLH1 immunostaining and methylated hMLH1.
9609758
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
26302849
[ "Gastric", "and", "colorectal", "cancers", "have", "a", "major", "impact", "on", "public", "health,", "and", "are", "the", "most", "common", "malignant", "tumors", "in", "China.", "The", "aim", "of", "this", "research", "was", "to", "study", "whether", "polymorphisms", "of", "CHCHD3P1-HSP90AB7P,", "GRID1,", "HSPA12A,", "PRLHR,", "SBF2,", "POLD3", "and", "C11orf93-C11orf92", "genes", "are", "associated", "with", "the", "risk", "of", "gastric", "and", "colorectal", "cancers", "in", "the", "Chinese", "Han", "population." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Gastric and colorectal cancers have a major impact on public health, and are the most common malignant tumors in China. The aim of this research was to study whether polymorphisms of CHCHD3P1-HSP90AB7P, GRID1, HSPA12A, PRLHR, SBF2, POLD3 and C11orf93-C11orf92 genes are associated with the risk of gastric and colorectal cancers in the Chinese Han population.
22810479
[ ":", "The", "pooled", "HR", "for", "the", "association", "between", "K-ras", "gene", "mutations", "and", "overall", "survival", "in", "patients", "with", "colorectal", "cancer", "was", "1.04", "(95%", "CI:", "0.99-1.10,", "p", "=", "0.11).", "Subgroup", "analysis", "showed", "significant", "reductions", "in", "the", "overall", "survival", "associated", "with", "mutations", "at", "K-ras", "codon", "12,", "the", "articles", "that", "reported", "HR", "directly,", "and", "the", "studies", "published", "before", "and", "after", "2005,", "although", "publication", "bias", "was", "present.", "All", "the", "associations", "disappeared", "after", "adjustment", "with", "the", "trim-and-fill", "method.", "The", "pooled", "HR", "of", "3", "studies", "examining", "mutations", "at", "K-ras", "codon", "13", "was", "1.47", "(95%", "CI:", "1.09-1.97,", "p", "=", "0.02),", "and", "no", "publication", "bias", "was", "observed.", "No", "significant", "association", "was", "observed", "in", "different", "study", "regions." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
: The pooled HR for the association between K-ras gene mutations and overall survival in patients with colorectal cancer was 1.04 (95% CI: 0.99-1.10, p = 0.11). Subgroup analysis showed significant reductions in the overall survival associated with mutations at K-ras codon 12, the articles that reported HR directly, and the studies published before and after 2005, although publication bias was present. All the associations disappeared after adjustment with the trim-and-fill method. The pooled HR of 3 studies examining mutations at K-ras codon 13 was 1.47 (95% CI: 1.09-1.97, p = 0.02), and no publication bias was observed. No significant association was observed in different study regions.
19706845
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
14645426
[ "In", "five", "of", "22", "patients", "with", "a", "positive", "first-degree", "family", "history", "for", "hereditary", "nonpolyposis", "colorectal", "cancer", "(HNPCC)-related", "cancers,", "pathogenic", "germline", "mutations", "were", "found", "(one", "MLH1", ",", "three", "MSH2", ",", "and", "one", "MSH6", ").", "Four", "mutation", "carriers", "belonged", "to", "families", "fulfilling", "the", "revised", "Amsterdam", "criteria.", "No", "mutations", "were", "found", "in", "the", "35", "patients", "without", "such", "family", "history", "(P", "=.006).", "MSI", "was", "detected", "in", "20", "of", "57", "cancers,", "among", "which", "four", "were", "from", "mutation", "carriers.", "In", "23", "of", "51", "cancers,", "one", "or", "more", "MMR", "protein", "was", "absent;", "in", "all", "five", "mutation", "carriers,", "immunostaining", "indicated", "the", "involved", "MMR", "gene." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
In five of 22 patients with a positive first-degree family history for hereditary nonpolyposis colorectal cancer (HNPCC)-related cancers, pathogenic germline mutations were found (one MLH1 , three MSH2 , and one MSH6 ). Four mutation carriers belonged to families fulfilling the revised Amsterdam criteria. No mutations were found in the 35 patients without such family history (P =.006). MSI was detected in 20 of 57 cancers, among which four were from mutation carriers. In 23 of 51 cancers, one or more MMR protein was absent; in all five mutation carriers, immunostaining indicated the involved MMR gene.
23132392
[ "Five", "somatic", "alterations", " ", "were", "observed:", "three", "in", "uterine", "leiomyosarcomas", "(3/41,", "7%;", "Gly44Ser,", "Ala38_Leu39ins7,", "Glu35_Leu36delinsVal),", "and", "two", "in", "CRC", "(2/392,", "0.5%;", "Gly44Cys,", "Ala67Val)." ]
[ 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Five somatic alterations were observed: three in uterine leiomyosarcomas (3/41, 7%; Gly44Ser, Ala38_Leu39ins7, Glu35_Leu36delinsVal), and two in CRC (2/392, 0.5%; Gly44Cys, Ala67Val).
21128281
[]
[]
23497483
[ "We", "found", "a", "higher", "mutation", "rate", "of", "somatic", "variants", "in", "tumor", "tissues", "in", "comparison", "with", "normal", "tissues,", "but", "no", "trend", "was", "observed", "for", "mutation", "properties.", "By", "applying", "a", "series", "of", "stringent", "filters,", "we", "identified", "418", "genes", "with", "tumor", "specific", "disruptive", "somatic", "variants.", "Of", "these", "genes,", "three", "genes", "in", "mucin", "protein", "family", "(", "MUC2", ",", "MUC4", ",", "and", "MU12", ")", "are", "of", "particular", "interests.", "It", "has", "been", "reported", "that", "the", "expression", "of", "mucin", "proteins", "was", "correlated", "with", "the", "progression", "of", "colorectal", "cancer", "therefore", "somatic", "variants", "within", "those", "genes", "can", "interrupt", "their", "normal", "expression", "and", "thus", "contribute", "to", "the", "tumorigenesis." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
We found a higher mutation rate of somatic variants in tumor tissues in comparison with normal tissues, but no trend was observed for mutation properties. By applying a series of stringent filters, we identified 418 genes with tumor specific disruptive somatic variants. Of these genes, three genes in mucin protein family ( MUC2 , MUC4 , and MU12 ) are of particular interests. It has been reported that the expression of mucin proteins was correlated with the progression of colorectal cancer therefore somatic variants within those genes can interrupt their normal expression and thus contribute to the tumorigenesis.
22396040
[]
[]
24435063
[ "Individuals", "with", "intermediate", "familial", "risk", "for", "colorectal", "cancer", "are", "highly", "interested", "in", "genomic", "testing", "for", "modest", "increases", "in", "disease", "risk,", "specifically", "unmarried", "persons,", "younger", "age", "groups", "and", "those", "with", "greater", "cancer", "fear." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Individuals with intermediate familial risk for colorectal cancer are highly interested in genomic testing for modest increases in disease risk, specifically unmarried persons, younger age groups and those with greater cancer fear.
24225759
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
25029911
[ "These", "results", "demonstrate", "that", "Egr-1", "Nasopharyngeal", "carcinoma-associated", "gene", "6", " ", "(", "NGX6", ")", "is", "involved", "in", "cellular", "growth,", "cell", "cycle", "progression", "and", "tumor", "angiogenesis.", "Previous", "studies", "have", "shown", "that", "NGX6", " ", "gene", "is", "down-regulated", "in", "colorectal", "cancer", "(CRC).", "However,", "little", "is", "known", "about", "its", "transcriptional", "regulation." ]
[ 0, 0, 0, 0, 1, 1, 2, 2, 2, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
These results demonstrate that Egr-1 Nasopharyngeal carcinoma-associated gene 6 ( NGX6 ) is involved in cellular growth, cell cycle progression and tumor angiogenesis. Previous studies have shown that NGX6 gene is down-regulated in colorectal cancer (CRC). However, little is known about its transcriptional regulation.
26925673
[ "##", "PURPOSE" ]
[ 0, 0 ]
## PURPOSE
22899730
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
17234021
[ "##", "METHODS" ]
[ 0, 0 ]
## METHODS
19706845
[ "Sixteen", "tagSNPs", "were", "selected,", "and", "13", "were", "successfully", "genotyped.", "A", "novel", "CYP2E1", "locus", "rs1329149", "and", "a", "known", "ALDH2", "locus", "rs671", "were", "found", "to", "be", "significantly", "associated", "with", "CRC", "risk.", "The", "adjusted", "OR", "was", "1.86", "(95%", "CI,", "1.12-3.09)", "for", "the", "rs671", "A/A", "genotype", "and", "4.04", "for", "the", "rs1329149", "T/T", "genotype", "(95%", "CI,", "2.44-6.70),", "compared", "with", "their", "common", "homozygous", "genotypes.", "Interaction", "was", "found", "between", "alcohol", "consumption", "and", "gene", "polymorphisms", "polymorphism", "polymorphism", " ", "rs1329149", "of", "CYP2E1", "and", "a", "known", "polymorphism", "rs671", "of", "ALDH2", "of", "alcohol", "metabolizing", "enzymes", "are", "associated", "with", "colorectal", "cancer", "in", "a", "southwestern", "Chinese", "population.", "\n\n\n", "##", "BACKGROUND" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Sixteen tagSNPs were selected, and 13 were successfully genotyped. A novel CYP2E1 locus rs1329149 and a known ALDH2 locus rs671 were found to be significantly associated with CRC risk. The adjusted OR was 1.86 (95% CI, 1.12-3.09) for the rs671 A/A genotype and 4.04 for the rs1329149 T/T genotype (95% CI, 2.44-6.70), compared with their common homozygous genotypes. Interaction was found between alcohol consumption and gene polymorphisms polymorphism polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal cancer in a southwestern Chinese population. ## BACKGROUND
9841584
[ "##", "PATIENTS" ]
[ 0, 0 ]
## PATIENTS
23132392
[ "The", "frequency", "of", "MED12", "exon", "2", "mutations", "was", "analysed", "in", "altogether", "1158", "tumours", "by", "direct", "sequencing.", "The", "tumour", "spectrum", "included", "mesenchymal", "tumours", "(extrauterine", "leiomyomas,", "endometrial", "polyps,", "lipomas,", "uterine", "leiomyosarcomas,", "other", "sarcomas,", "gastro-intestinal", "stromal", "tumours),", "hormone-dependent", "tumours", "(breast", "and", "ovarian", "cancers),", "haematological", "malignancies", "(acute", "myeloid", "leukaemias,", "acute", "lymphoid", "leukaemias,", "myeloproliferative", "neoplasms),", "and", "tumours", "associated", "with", "abnormal", "Wnt-signalling", "(colorectal", "cancers", "(CRC))." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
The frequency of MED12 exon 2 mutations was analysed in altogether 1158 tumours by direct sequencing. The tumour spectrum included mesenchymal tumours (extrauterine leiomyomas, endometrial polyps, lipomas, uterine leiomyosarcomas, other sarcomas, gastro-intestinal stromal tumours), hormone-dependent tumours (breast and ovarian cancers), haematological malignancies (acute myeloid leukaemias, acute lymphoid leukaemias, myeloproliferative neoplasms), and tumours associated with abnormal Wnt-signalling (colorectal cancers (CRC)).
22899730
[ "##", "METHODS" ]
[ 0, 0 ]
## METHODS
26302849
[ "Our", "results", "provide", "evidence", "that", "variants", "of", "PRLHR", "gene", "are", "a", "protective", "factor", "in", "colorectal", "cancer", "and", "variants", "of", "HSPA12A", "HSPA12A", " ", "and", "risk", "of", "gastric", "and", "colorectal", "cancer", "in", "the", "Chinese", "Han", "population.", "\n\n\n", "##", "BACKGROUND" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Our results provide evidence that variants of PRLHR gene are a protective factor in colorectal cancer and variants of HSPA12A HSPA12A and risk of gastric and colorectal cancer in the Chinese Han population. ## BACKGROUND
25374237
[ "##", "MATERIALS", "AND", "METHODS" ]
[ 0, 0, 0, 0 ]
## MATERIALS AND METHODS
12534642
[ "From", "genomic", "DNA,", "114", "British", "Caucasians", "(49", "colorectal", "cancer", "cases", "and", "65", "controls)", "were", "genotyped", "for", "the", "CYP1A2", " ", "polymorphisms", " ", "-3858G-->A", "(allele", "CYP1A2*1C),", "-2464T-->delT", "(CYP1A2*1D),", "-740T-->G", "(CYP1A2*1E", "and", "*1G),", "-164A-->C", "(CYP1A2*1F),", "63C-->G", "(CYP1A2*2),", "and", "1545T-->C", "(alleles", "CYP1A2*1B,", "*1G,", "*1H", "and", "*3),", "using", "polymerase", "chain", "reaction-restriction", "fragment", "length", "polymorphism", "assays.", "All", "patients", "and", "controls", "were", "phenotyped", "for", "CYP1A2", "cytochrome", "P450", "CYP1A2", " ", "gene", "(", "CYP1A2", "Polymorphisms", " ", "in", "the", "cytochrome", "P450", "CYP1A2", "gene", "(CYP1A2)", "in", "colorectal", "cancer", "patients", "and", "controls:", "allele", "frequencies,", "linkage", "disequilibrium", "and", "influence", "on", "caffeine", "metabolism.", "\n\n\n", "##", "AIMS" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 2, 2, 0, 0, 0, 1, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
From genomic DNA, 114 British Caucasians (49 colorectal cancer cases and 65 controls) were genotyped for the CYP1A2 polymorphisms -3858G-->A (allele CYP1A2*1C), -2464T-->delT (CYP1A2*1D), -740T-->G (CYP1A2*1E and *1G), -164A-->C (CYP1A2*1F), 63C-->G (CYP1A2*2), and 1545T-->C (alleles CYP1A2*1B, *1G, *1H and *3), using polymerase chain reaction-restriction fragment length polymorphism assays. All patients and controls were phenotyped for CYP1A2 cytochrome P450 CYP1A2 gene ( CYP1A2 Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. ## AIMS
12000733
[]
[]
9731891
[]
[]
26302849
[ "The", "genotype", "\"A/T\"", "of", "rs12413624", "in", "PRLHR", "gene", "was", "associated", "with", "a", "decreased", "risk", "of", "colorectal", "cancer", "in", "allele", "model", "analysis", "[odds", "ratio", "(OR)", " ", "=", " ", "0.81;", "95%", "confidence", "interval", "(CI)", " ", "=", " ", "0.68-0.97;", "p", " ", "=", " ", "0.018]", "and", "log-additive", "model", "analysis", "(OR", " ", "=", " ", "0.81;", "95%", "CI", " ", "=", " ", "0.66-0.98;", "p", " ", "=", " ", "0.032).", "The", "genotype", "\"A/G\"", "of", "rs1665650", "in", "HSPA12A", "gene", "was", "associated", "with", "a", "decreased", "risk", "of", "gastric", "cancer", "in", "overdominant", "model", "analysis", "(OR", " ", "=", " ", "0.77;", "95%", "CI", " ", "=", " ", "0.60-0.99;", "p", " ", "=", " ", "0.038)." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
The genotype "A/T" of rs12413624 in PRLHR gene was associated with a decreased risk of colorectal cancer in allele model analysis [odds ratio (OR)   =   0.81; 95% confidence interval (CI)   =   0.68-0.97; p   =   0.018] and log-additive model analysis (OR   =   0.81; 95% CI   =   0.66-0.98; p   =   0.032). The genotype "A/G" of rs1665650 in HSPA12A gene was associated with a decreased risk of gastric cancer in overdominant model analysis (OR   =   0.77; 95% CI   =   0.60-0.99; p   =   0.038).
17096342
[ "Disease", "expression", "in", "hereditary", "nonpolyposis", "colorectal", "cancer", "(HNPCC)", "cannot", "be", "readily", "explained", "by", "mutation", "site", "in", "the", "respective", "DNA", "mismatch", "repair", "genes", "associated", "with", "this", "disorder.", "One", "explanation", "is", "the", "role", "of", "modifying", "genes", "that", "can", "either", "promote", "or", "prevent", "disease", "development", "on", "a", "background", "of", "increased", "risk.", "Two", "single", "nucleotide", "polymorphisms", "in", "MDM2", "and", "TP53", "have", "been", "shown", "to", "be", "associated", "with", "younger", "ages", "of", "disease", "onset", "in", "HNPCC", "(TP53)", "and", "Li-Fraumeni", "syndrome", "(MDM2).", "In", "this", "study", "220", "HNPCC", "patients", "were", "examined,", "from", "Australia", "and", "Poland,", "all", "characterized", "at", "the", "molecular", "level", "to", "determine", "the", "frequency", "of", "the", "MDM2", "SNP309", "T>G", "and", "to", "assess", "its", "influence", "on", "disease", "expression.", "The", "results", "were", "then", "pooled", "with", "the", "results", "of", "a", "previous", "study", "to", "assess", "the", "combined", "influence", "of", "the", "MDM2", "SNP309", "T>G", "and", "TP53", "SNP", "R72P", "MDM2", ").", "In", "this", "study", "220", "HNPCC", "patients", "were", "examined,", "from", "Australia", "and", "Poland,", "all", "characterized", "at", "the", "molecular", "level", "to", "determine", "the", "frequency", "of", "the", "MDM2", "SNP309", "T>G", "and", "to", "assess", "its", "influence", "on", "disease", "expression.", "The", "results", "were", "then", "pooled", "with", "the", "results", "of", "a", "previous", "study", "to", "assess", "the", "combined", "influence", "of", "the", "MDM2", "SNP309", "T>G", "and", "TP53", "SNP", "R72P.", "A", "significant", "difference", "was", "observed", "between", "CRC", "patients", "and", "unaffected", "MMR", "gene", "mutation", " ", "carriers", "over", "the", "age", "of", "45", "years", "(p", "=", "0.01).", "The", "unaffected", "MMR", "gene", "mutation", "carriers", "over", "the", "age", "of", "45", "years", "who", "carry", "the", "G", "allele", "have", "a", "reduced", "risk", "of", "developing", "CRC.", "The", "results", "indicate", "that", "the", "MDM2", "SNP309,", "alone", "or", "in", "combination", "with", "TP53", "R72P,", "does", "not", "influence", "age", "of", "diagnosis", "of", "CRC", "in", "individuals", "with", "HNPCC.", "In", "conclusion,", "the", "data", "indicates", "the", "G", "allele", "of", "MDM2", " ", "SNP309", "might", "have", "a", "protective", "effect", "on", "disease", "development", "in", "HNPCC", "patients", "and", "that", "age", "of", "diagnosis", "of", "CRC", "is", "not", "associated", "with", "MDM2", "SNP309", " ", "might", "have", "a", "protective", "effect", "on", "disease", "development", "in", "HNPCC", "patients", "and", "that", "age", "of", "diagnosis", "of", "CRC", "is", "not", "associated", "with", "MDM2", "SNP309", "or", "TP53", "SNP309", "MDM2", " ", "SNP309", "T>G", " ", "alone", "or", "in", "combination", "with", "the", "TP53", " ", "R72P", "polymorphism", "does", "not", "appear", "to", "influence", "disease", "expression", "and", "age", "of", "diagnosis", "of", "colorectal", "cancer", "in", "HNPCC", "patients." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 13, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 3, 1, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Disease expression in hereditary nonpolyposis colorectal cancer (HNPCC) cannot be readily explained by mutation site in the respective DNA mismatch repair genes associated with this disorder. One explanation is the role of modifying genes that can either promote or prevent disease development on a background of increased risk. Two single nucleotide polymorphisms in MDM2 and TP53 have been shown to be associated with younger ages of disease onset in HNPCC (TP53) and Li-Fraumeni syndrome (MDM2). In this study 220 HNPCC patients were examined, from Australia and Poland, all characterized at the molecular level to determine the frequency of the MDM2 SNP309 T>G and to assess its influence on disease expression. The results were then pooled with the results of a previous study to assess the combined influence of the MDM2 SNP309 T>G and TP53 SNP R72P MDM2 ). In this study 220 HNPCC patients were examined, from Australia and Poland, all characterized at the molecular level to determine the frequency of the MDM2 SNP309 T>G and to assess its influence on disease expression. The results were then pooled with the results of a previous study to assess the combined influence of the MDM2 SNP309 T>G and TP53 SNP R72P. A significant difference was observed between CRC patients and unaffected MMR gene mutation carriers over the age of 45 years (p = 0.01). The unaffected MMR gene mutation carriers over the age of 45 years who carry the G allele have a reduced risk of developing CRC. The results indicate that the MDM2 SNP309, alone or in combination with TP53 R72P, does not influence age of diagnosis of CRC in individuals with HNPCC. In conclusion, the data indicates the G allele of MDM2 SNP309 might have a protective effect on disease development in HNPCC patients and that age of diagnosis of CRC is not associated with MDM2 SNP309 might have a protective effect on disease development in HNPCC patients and that age of diagnosis of CRC is not associated with MDM2 SNP309 or TP53 SNP309 MDM2 SNP309 T>G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients.
7905818
[ "Combined", "use", "of", "molecular", "and", "biomarkers", "for", "presymptomatic", "carrier", "risk", "assessment", "in", "familial", "adenomatous", "polyposis:", "implications", "for", "screening", "guidelines." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Combined use of molecular and biomarkers for presymptomatic carrier risk assessment in familial adenomatous polyposis: implications for screening guidelines.
9609758
[ "Thirty-three", "sporadic", "colorectal", "cancers", "and", "20", "normal", "colonic", "tissues", "were", "explored", "by", "immunohistochemistry", "for", "the", "expression", "of", "type", "I", "and", "type", "II", "TGF-beta", "receptors.", "Eighteen", "tumor", "and", "20", "normal", "samples", "were", "used", "for", "radioactive", "thermocycling", "and", "sequencing", "of", "the", "two", "microsatellite-like", "regions", "of", "the", "type", "II", "receptor." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Thirty-three sporadic colorectal cancers and 20 normal colonic tissues were explored by immunohistochemistry for the expression of type I and type II TGF-beta receptors. Eighteen tumor and 20 normal samples were used for radioactive thermocycling and sequencing of the two microsatellite-like regions of the type II receptor.
23603433
[]
[]
10962562
[ "Breast", "cancer", "susceptibility", "gene", "BRCA1", "has", "been", "implicated", "in", "the", "control", "of", "gene", "regulation", "and", "such", "regulated", "genes", "are", "thought", "to", "mediate", "the", "biological", "role", "of", "BRCA1.", "Overexpression", "of", "BRCA1", "induces", "GADD45,", "a", "p53-regulated", "and", "stress-inducible", "gene.", "However,", "the", "molecular", "mechanism", "by", "which", "BRCA1", "induces", "the", "expression", "GADD45", "remains", "unclear.", "In", "this", "report,", "we", "have", "shown", "that", "the", "GADD45", "promoter", "is", "strongly", "activated", "following", "expression", "of", "wild-type", "BRCA1.", "In", "contrast,", "both", "the", "tumor-derived", "BRCA1", "mutants", "(p1749R", "and", "Y1853insA", "BRCA1", "GADD45", " ", "promoter", "is", "strongly", "activated", "following", "expression", "of", "wild-type", "BRCA1.", "In", "contrast,", "both", "the", "tumor-derived", "BRCA1", "mutants", "(p1749R", "and", "Y1853insA)", "and", "truncated", "BRCA1", "BRCA1", ".", "In", "contrast,", "both", "the", "tumor-derived", "BRCA1", "mutants", " ", "(p1749R", "and", "Y1853insA)", "and", "truncated", "BRCA1", "mutant", "protein", "(Delta500", "-", "1863", "BRCA1),", "which", "lack", "transactivation", "activity,", "were", "unable", "to", "activate", "the", "GADD45", "promoter", ",", "indicating", "that", "the", "BRCA1-mediated", "activation", "of", "the", "GADD45", "promoter", "requires", "normal", "transcriptional", "properties", "of", "BRCA1.", "BRCA1", "did", "not", "induce", "the", "c-Jun", "and", "c-fos", "promoters,", "which", "rules", "out", "a", "general", "effect", "of", "BRCA1", "on", "other", "immediate-responsive", "genes.", "Expression", "of", "the", "human", "papillomavirus", "E6", "and", "the", "dominant-negative", "mutant", "p53", "proteins", "had", "no", "effect", "on", "the", "induction", "of", "the", "GADD45", "promoter", "by", "BRCA1,", "suggesting", "that", "activation", "of", "the", "GADD45", "promoter", "by", "BRCA1", "is", "independent", "of", "cellular", "p53", "function.", "With", "the", "5'-deletion", "analysis,", "the", "BRCA1-responsive", "element", "of", "the", "GADD45", "promoter", "was", "mapped", "at", "the", "region", "from", "-121", "to", "-75.", "Disruption", "of", "this", "region", "resulted", "in", "the", "abrogation", "of", "BRCA1", "activation", "of", "the", "GADD45", "promoter.", "Taken", "together,", "these", "results", "demonstrate", "that", "the", "mechanism", "by", "which", "BRCA1", "induces", "GADD45", "is", "mainly", "through", "the", "transactivation", "of", "the", "GADD45", "promoter,", "further", "demonstrating", "the", "evidence", "that", "GADD45", "acts", "as", "one", "of", "the", "BRCA1-regulated", "genes.", "Oncogene", "(2000)", "19,", "4050", "-", "4057." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 13, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Breast cancer susceptibility gene BRCA1 has been implicated in the control of gene regulation and such regulated genes are thought to mediate the biological role of BRCA1. Overexpression of BRCA1 induces GADD45, a p53-regulated and stress-inducible gene. However, the molecular mechanism by which BRCA1 induces the expression GADD45 remains unclear. In this report, we have shown that the GADD45 promoter is strongly activated following expression of wild-type BRCA1. In contrast, both the tumor-derived BRCA1 mutants (p1749R and Y1853insA BRCA1 GADD45 promoter is strongly activated following expression of wild-type BRCA1. In contrast, both the tumor-derived BRCA1 mutants (p1749R and Y1853insA) and truncated BRCA1 BRCA1 . In contrast, both the tumor-derived BRCA1 mutants (p1749R and Y1853insA) and truncated BRCA1 mutant protein (Delta500 - 1863 BRCA1), which lack transactivation activity, were unable to activate the GADD45 promoter , indicating that the BRCA1-mediated activation of the GADD45 promoter requires normal transcriptional properties of BRCA1. BRCA1 did not induce the c-Jun and c-fos promoters, which rules out a general effect of BRCA1 on other immediate-responsive genes. Expression of the human papillomavirus E6 and the dominant-negative mutant p53 proteins had no effect on the induction of the GADD45 promoter by BRCA1, suggesting that activation of the GADD45 promoter by BRCA1 is independent of cellular p53 function. With the 5'-deletion analysis, the BRCA1-responsive element of the GADD45 promoter was mapped at the region from -121 to -75. Disruption of this region resulted in the abrogation of BRCA1 activation of the GADD45 promoter. Taken together, these results demonstrate that the mechanism by which BRCA1 induces GADD45 is mainly through the transactivation of the GADD45 promoter, further demonstrating the evidence that GADD45 acts as one of the BRCA1-regulated genes. Oncogene (2000) 19, 4050 - 4057.
9841584
[ "Immediate", "prophylactic", "colectomy;", "delayed", "colectomy", "on", "the", "basis", "of", "age,", "adenoma,", "or", "diagnosis", "of", "colorectal", "cancer;", "and", "endoscopic", "surveillance.", "Prophylactic", "surgical", "options", "were", "proctocolectomy", "with", "ileoanal", "anastomosis", "and", "subtotal", "colectomy", "with", "ileorectal", "anastomosis." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Immediate prophylactic colectomy; delayed colectomy on the basis of age, adenoma, or diagnosis of colorectal cancer; and endoscopic surveillance. Prophylactic surgical options were proctocolectomy with ileoanal anastomosis and subtotal colectomy with ileorectal anastomosis.
23512527
[ "We", "evaluated", "long-term", "psychosocial", "consequences", "of", "predictive", "genetic", "testing,", "and", "surveillance", "behaviour", "in", "Lynch", "syndrome", "(LS).", "We", "conducted", "a", "longitudinal", "study", "of", "208", "participants", "(62", "LS", "mutation", " ", "carriers", "and", "146", "non-carriers)", "who", "provided", "information", "on", "general", "anxiety", "(State-Trait", "Anxiety", "Inventory),", "fear", "of", "cancer", "and", "dying,", "satisfaction", "with", "life,", "risk", "and", "test", "perceptions,", "and", "surveillance", "behaviour", "in", "the", "baseline", "questionnaire", "before", "testing,", "and", "1", "month,", "1", "year", "and", "7", "years", "post-test.", "At", "7", "years,", "most", "of", "the", "psychosocial", "variables", "remained", "unchanged,", "regardless", "of", "mutation", " ", "status.", "Carriers", "tended", "to", "underestimate", "their", "colorectal", "cancer", "risk", "but", "were", "more", "worried", "about", "their", "cancer", "risk", "than", "their", "counterparts.", "Non-carriers", "reported", "a", "higher", "degree", "of", "satisfaction", "with", "their", "testing", "decisions", "(P", "<", "0.05),", "but", "had", "more", "doubts", "concerning", "test", "result", "validity", "than", "carriers", "(P", "<", "0.05).", "All", "carriers", "attended", "a", "post-test", "colonoscopy", "surveillance,", "while", "16%", "of", "non-carriers", "reported", "colonoscopy", "examinations.", "Those", "non-carriers", "with", "doubts", "about", "test", "validity", "were", "more", "likely", "(P", "=", "0.019)", "to", "report", "post-test", "colonoscopy.", "Of", "the", "carriers,", "17%", "had", "an", "interval", "longer", "than", "3", "years", "between", "their", "colonoscopies.", "Fear", "of", "dying", "soon,", "measured", "at", "1-month", "post-test", "follow-up", "was", "the", "only", "psychosocial", "variable", "predicting", "non-compliance", "in", "recommended", "surveillance.", "No", "adverse", "psychosocial", "consequences", "were", "detected,", "and", "respondents", "were", "satisfied", "with", "their", "decision", "to", "testing", "7", "years", "post-test.", "Among", "the", "carriers,", "solely", "fear", "of", "dying", "soon", "predicted", "non-compliance", "in", "recommended", "surveillance.", "Some", "non-carriers", "were", "still", "worried", "about", "their", "risk", "and", "had", "doubts", "about", "the", "validity", "of", "their", "genetic", "testing", "results", "predicting", "post-test", "colonoscopy." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
We evaluated long-term psychosocial consequences of predictive genetic testing, and surveillance behaviour in Lynch syndrome (LS). We conducted a longitudinal study of 208 participants (62 LS mutation carriers and 146 non-carriers) who provided information on general anxiety (State-Trait Anxiety Inventory), fear of cancer and dying, satisfaction with life, risk and test perceptions, and surveillance behaviour in the baseline questionnaire before testing, and 1 month, 1 year and 7 years post-test. At 7 years, most of the psychosocial variables remained unchanged, regardless of mutation status. Carriers tended to underestimate their colorectal cancer risk but were more worried about their cancer risk than their counterparts. Non-carriers reported a higher degree of satisfaction with their testing decisions (P < 0.05), but had more doubts concerning test result validity than carriers (P < 0.05). All carriers attended a post-test colonoscopy surveillance, while 16% of non-carriers reported colonoscopy examinations. Those non-carriers with doubts about test validity were more likely (P = 0.019) to report post-test colonoscopy. Of the carriers, 17% had an interval longer than 3 years between their colonoscopies. Fear of dying soon, measured at 1-month post-test follow-up was the only psychosocial variable predicting non-compliance in recommended surveillance. No adverse psychosocial consequences were detected, and respondents were satisfied with their decision to testing 7 years post-test. Among the carriers, solely fear of dying soon predicted non-compliance in recommended surveillance. Some non-carriers were still worried about their risk and had doubts about the validity of their genetic testing results predicting post-test colonoscopy.
26710976
[]
[]
23132392
[ "##", "CONCLUSION" ]
[ 0, 0 ]
## CONCLUSION
24576032
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
15987719
[]
[]
14734469
[ "We", "observed", "a", "strong", "correlation", "of", "BRAF", "mutation", "with", "hMLH1", "promoter", "methylation.", "BRAF", "mutations", "were", "present", "in", "13", "of", "15", "(87%)", "of", "the", "colorectal", "cell", "lines", "and", "cancers", "with", "methylated", "hMLH1,", "whereas", "only", "4", "of", "91", "(4%)", "of", "the", "cell", "lines", "and", "cancers", "with", "unmethylated", "hMLH1", "carried", "the", "mutations", "(P", "<", "0.00001).", "Sixteen", "of", "17", "mutations", "were", "at", "residue", "599", "(V599E).", "A", "BRAF", "mutation", "was", "also", "identified", "at", "residue", "463", " ", "(", "G463V", ")", "in", "one", "cell", "line.", "In", "addition,", "BRAF", "mutations", "were", "not", "found", "in", "any", "cancers", "or", "cell", "lines", "with", "K-ras", "mutations", "methylation", " ", "status", "of", "the", "hMLH1", "gene", "was", "measured", "by", "either", "sequencing", "or", "restriction", "enzyme", "digestion", "after", "NaHSO(3)", "treatment." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 0, 0, 13, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 5, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
We observed a strong correlation of BRAF mutation with hMLH1 promoter methylation. BRAF mutations were present in 13 of 15 (87%) of the colorectal cell lines and cancers with methylated hMLH1, whereas only 4 of 91 (4%) of the cell lines and cancers with unmethylated hMLH1 carried the mutations (P < 0.00001). Sixteen of 17 mutations were at residue 599 (V599E). A BRAF mutation was also identified at residue 463 ( G463V ) in one cell line. In addition, BRAF mutations were not found in any cancers or cell lines with K-ras mutations methylation status of the hMLH1 gene was measured by either sequencing or restriction enzyme digestion after NaHSO(3) treatment.
9439149
[ "##", "CONCLUSION" ]
[ 0, 0 ]
## CONCLUSION
25029911
[ "These", "results", "demonstrate", "that", "Egr-1", "regulates", "NGX6", "gene", "transcription", "through", "an", "overlapping", "Sp1/Egr-1", "binding", "site", "as", "a", "positive", "regulator", "of", "NGX6", "Egr-1", "mutation", " ", "construct", "methods", "and", "luciferase", "assays.", "Results", "from", "Electrophoretic", "mobility", "shift", "assays", "(EMSA)", "and", "Chromatin", "immunoprecipitation", "(ChIP)", "revealed", "that", "Early", "growth", "response", "gene", "1", "(Egr-1)", "binds", "to", "the", "Sp1/", "Egr-1", "Sp1", "Egr-1", " ", "overlapping", "site", "in", "the", "promoter.", "\n\n\n", "##", "BACKGROUND" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
These results demonstrate that Egr-1 regulates NGX6 gene transcription through an overlapping Sp1/Egr-1 binding site as a positive regulator of NGX6 Egr-1 mutation construct methods and luciferase assays. Results from Electrophoretic mobility shift assays (EMSA) and Chromatin immunoprecipitation (ChIP) revealed that Early growth response gene 1 (Egr-1) binds to the Sp1/ Egr-1 Sp1 Egr-1 overlapping site in the promoter. ## BACKGROUND
23497483
[ "Somatic", "variants,", "which", "occur", "in", "the", "genome", "of", "all", "cells,", "are", "well", "accepted", "to", "play", "a", "critical", "role", "in", "cancer", "development,", "as", "their", "accumulation", "in", "genes", "could", "affect", "cell", "proliferations", "and", "cell", "cycle." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Somatic variants, which occur in the genome of all cells, are well accepted to play a critical role in cancer development, as their accumulation in genes could affect cell proliferations and cell cycle.
19276868
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
12534642
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
22545919
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
1916131
[ "[Immunochemical", "evidence", "of", "a", "mutated", "p53", "protein", "expressed", "in", "human", "colorectal", "adenocarcinoma]." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[Immunochemical evidence of a mutated p53 protein expressed in human colorectal adenocarcinoma].
27070770
[ "##", "MATERIAL", "AND", "METHODS" ]
[ 0, 0, 0, 0 ]
## MATERIAL AND METHODS
17454882
[ "In", "recent", "years", "persons", "at", "risk", "for", "colorectal", "cancers", "(CRC)", "have", "been", "subjected", "to", "follow-up", "with", "colonoscopy", "in", "many", "centres.", "There", "is,", "however,", "limited", "knowledge", "about", "the", "effect", "of", "such", "interventions.", "The", "objective", "of", "this", "study", "was", "to", "report", "the", "results", "of", "our", "observations", "during", "the", "past", "15", "years." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
In recent years persons at risk for colorectal cancers (CRC) have been subjected to follow-up with colonoscopy in many centres. There is, however, limited knowledge about the effect of such interventions. The objective of this study was to report the results of our observations during the past 15 years.
12534642
[ "Polymorphisms", "in", "the", "cytochrome", "P450", "CYP1A2", "gene", "(CYP1A2)", "in", "colorectal", "cancer", "patients", "and", "controls:", "allele", "frequencies,", "linkage", "disequilibrium", "and", "influence", "on", "caffeine", "metabolism.", "\n\n\n", "##", "AIMS" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. ## AIMS
22810479
[ "##", "STUDY", "SELECTION" ]
[ 0, 0, 0 ]
## STUDY SELECTION
22899730
[ "The", "presence", "of", "a", "BRAF", "c.1799T>A", "(p.V600E)", "mutation", "is", "associated", "with", "significantly", "poorer", "prognosis", "after", "CRC", "diagnosis", "among", "subgroups", "of", "patients." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
The presence of a BRAF c.1799T>A (p.V600E) mutation is associated with significantly poorer prognosis after CRC diagnosis among subgroups of patients.
26416897
[ "We", "analyzed", "genomic", "DNA", "extracted", "from", "samples", "of", "patients", "receiving", "bevacizumab", "plus", "FOLFIRI", "as", "a", "first-line", "treatment", "using", "PCR-based", "direct", "sequencing.", "Twelve", "functional", "single-nucleotide", "polymorphisms", " ", "in", "eight", "genes", "(CCL2,", "CCR2,", "HRG,", "PIGF,", "NFKB1,", "TBK1,", "CCL18,", "and", "IRF3)", "were", "tested", "for", "associations", "with", "clinical", "outcomes", "in", "a", "discovery", "cohort", "of", "228", "participants", "in", "TRIBE", "trial", "(NCT00719797),", "then", "validated", "in", "248", "KRAS", "exon2", "(KRAS)", "wild-type", "participants", "in", "FIRE3", "trial", "(NCT00433927).", "FIRE3-cetuximab", "cohort", "served", "as", "a", "negative", "control." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
We analyzed genomic DNA extracted from samples of patients receiving bevacizumab plus FOLFIRI as a first-line treatment using PCR-based direct sequencing. Twelve functional single-nucleotide polymorphisms in eight genes (CCL2, CCR2, HRG, PIGF, NFKB1, TBK1, CCL18, and IRF3) were tested for associations with clinical outcomes in a discovery cohort of 228 participants in TRIBE trial (NCT00719797), then validated in 248 KRAS exon2 (KRAS) wild-type participants in FIRE3 trial (NCT00433927). FIRE3-cetuximab cohort served as a negative control.
9731891
[ "Microsatellite", "instability", "is", "prone", "to", "occur", "in", "sporadic", "right", "colon", "carcinoma", "during", "tumor", "growth", "and", "is", "not", "associated", "significantly", "with", "mutations", "in", "the", "hMLH1", "and", "hMSH2", "mismatch", "repair", "genes", "or", "in", "the", "p53", "gene.", "Concomitant", "detection", "of", "microsatellite", "instability", "and", "p53", "p53", " ", "mutations", "correlated", "with", "lymph", "node", "metastases", "from", "right", "colon", "carcinoma", "cases", "(61%),", "and", "all", "cases", "with", "p53", "mutations", "and", "microsatellite", "instability", "were", "AJCC/UICC", "Stage", "III", "(Dukes", "Stage", "C).", "In", "the", "right", "colon", "carcinoma", "cases", "the", "rate", "of", "microsatellite", "instability", "was", "related", "to", "the", "tumor", "size", "(19%", "in", "tumors", "measuring", "<", "4", "cm,", "and", "34%", "in", "tumors", "measuring", ">", "4", "cm).", "No", "correlation", "between", "microsatellite", "instability", "and", "p53", "mutations", "p53", " ", "mutations", "was", "detected.", "In", "the", "left", "colon", "carcinoma", "cases,", "p53", "mutations", "p53", " ", "mutations", "were", "detected", "in", "41%", "of", "tumors", "and", "microsatellite", "instability", "in", "14%;", "neither", "finding", "was", "related", "to", "the", "tumor", "size.", "Mutations", "of", "the", "hMLH1", "microsatellite", "instability", " ", "in", "14%;", "neither", "finding", "was", "related", "to", "the", "tumor", "size.", "Mutations", " ", "of", "the", "hMLH1", "and", "hMSH2", " ", "mismatch", "repair", "genes", "were", "detected", "in", "7", "of", "24", "cases", "with", "marked", "microsatellite", "instability." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Microsatellite instability is prone to occur in sporadic right colon carcinoma during tumor growth and is not associated significantly with mutations in the hMLH1 and hMSH2 mismatch repair genes or in the p53 gene. Concomitant detection of microsatellite instability and p53 p53 mutations correlated with lymph node metastases from right colon carcinoma cases (61%), and all cases with p53 mutations and microsatellite instability were AJCC/UICC Stage III (Dukes Stage C). In the right colon carcinoma cases the rate of microsatellite instability was related to the tumor size (19% in tumors measuring < 4 cm, and 34% in tumors measuring > 4 cm). No correlation between microsatellite instability and p53 mutations p53 mutations was detected. In the left colon carcinoma cases, p53 mutations p53 mutations were detected in 41% of tumors and microsatellite instability in 14%; neither finding was related to the tumor size. Mutations of the hMLH1 microsatellite instability in 14%; neither finding was related to the tumor size. Mutations of the hMLH1 and hMSH2 mismatch repair genes were detected in 7 of 24 cases with marked microsatellite instability.
12534642
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
1299227
[ "Colorectal", "carcinoma.", "DNA", "ploidy", "pattern", "and", "prognosis", "with", "reference", "to", "tumor", "DNA", "heterogeneity." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Colorectal carcinoma. DNA ploidy pattern and prognosis with reference to tumor DNA heterogeneity.
24568449
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
23497483
[ "In", "order", "to", "understand", "the", "role", "of", "somatic", "mutations", "in", "human", "colorectal", "cancers,", "we", "characterized", "the", "mutation", " ", "spectrum", "in", "two", "colorectal", "tumor", "tissues", "and", "their", "matched", "normal", "tissues,", "by", "analyzing", "deep-sequenced", "transcriptome", "data." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 9, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
In order to understand the role of somatic mutations in human colorectal cancers, we characterized the mutation spectrum in two colorectal tumor tissues and their matched normal tissues, by analyzing deep-sequenced transcriptome data.
16924054
[ "We", "report", "the", "case", "of", "a", "54-year-old", "man", "with", "a", "2-year", "history", "of", "skin-colored", "papules", "clinically", "reminiscent", "of", "large", "sebaceous", "hyperplasias", "on", "the", "nose", "and", "back,", "but", "histologically", "diagnosed", "as", "sebaceous", "adenomas", "and", "epitheliomas.", "His", "family", "history", "was", "positive", "for", "colon", "cancer", "in", "the", "mother", "and", "2", "brothers.", "A", "colonoscopy", "done", "during", "the", "hospitalization", "revealed", "2", "sessile", "polyps", "in", "the", "left", "colon,", "both", "showing", "a", "low-grade", "dysplasia", "on", "the", "biopsy", "specimen.", "Immunohistochemical", "staining", "performed", "on", "the", "cutaneous", "and", "colic", "biopsy", "specimens", "revealed", "a", "lack", "of", "expression", "of", "MSH-2", "and", "MSH-6.", "Genetic", "testing", "revealed", "microsatellite", "instability", "in", "the", "colon", "and", "cutaneous", "tumors." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
We report the case of a 54-year-old man with a 2-year history of skin-colored papules clinically reminiscent of large sebaceous hyperplasias on the nose and back, but histologically diagnosed as sebaceous adenomas and epitheliomas. His family history was positive for colon cancer in the mother and 2 brothers. A colonoscopy done during the hospitalization revealed 2 sessile polyps in the left colon, both showing a low-grade dysplasia on the biopsy specimen. Immunohistochemical staining performed on the cutaneous and colic biopsy specimens revealed a lack of expression of MSH-2 and MSH-6. Genetic testing revealed microsatellite instability in the colon and cutaneous tumors.
14734469
[ "The", "BRAF", "hMLH1", ",", "but", "not", "in", "hereditary", "nonpolyposis", "colorectal", "cancer.", "\n\n\n", "##", "PURPOSE" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
The BRAF hMLH1 , but not in hereditary nonpolyposis colorectal cancer. ## PURPOSE
10822375
[ "Inactivation", "of", "DNA-mismatch", "repair", "underlies", "the", "genesis", "of", "microsatellite", "unstable", "(MSI)", "colon", "cancers.", "hPMS2", "is", "one", "of", "several", "genes", "encoding", "components", "of", "the", "DNA-mismatch", "repair", "complex,", "and", "germline", "hPMS2", "mutations", "have", "been", "found", "in", "a", "few", "kindreds", "with", "hereditary", "nonpolyposis", "colorectal", "carcinoma", "(HNPCC),", "in", "whom", "hereditary", "MSI", "colon", "cancers", "develop.", "However,", "mice", "bearing", "null", "hPMS2", "genes", "do", "not", "develop", "colon", "cancers", "and", "hPMS2", "mutations", "in", "sporadic", "human", "colon", "cancers", "have", "not", "been", "described.", "Here", "we", "report", "that", "in", "Vaco481", "colon", "cancer", "the", "hPMS2", "gene", "is", "inactivated", "by", "somatic", "mutations", "of", "both", "hPMS2", "alleles.", "The", "cell", "line", "derived", "from", "this", "tumor", "is", "functionally", "deficient", "in", "DNA", "mismatch", "repair.", "This", "deficiency", "can", "be", "biochemically", "complemented", "by", "addition", "of", "a", "purified", "hMLH1", "-hPMS2", "(hMutLalpha)", "complex.", "The", "hPMS2", "deficient", "Vaco481", "cancer", "cell", "line", "demonstrates", "microsatellite", "instability,", "an", "elevated", "HPRT", "gene", "mutation", "rate,", "and", "resistance", "to", "the", "cytotoxicity", "of", "the", "alkylator", "MNNG.", "We", "conclude", "that", "somatic", "inactivation", "of", "hPMS2", "can", "play", "a", "role", "in", "development", "of", "sporadic", "MSI", "colon", "cancer", "expressing", "the", "full", "range", "of", "cancer", "phenotypes", "associated", "with", "inactivation", "microsatellite", "instability", "mutation", " ", "of", "hPMS2", "as", "a", "possible", "cause", "of", "sporadic", "human", "colon", "cancer", "with", "microsatellite", "instability." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 3, 4, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Inactivation of DNA-mismatch repair underlies the genesis of microsatellite unstable (MSI) colon cancers. hPMS2 is one of several genes encoding components of the DNA-mismatch repair complex, and germline hPMS2 mutations have been found in a few kindreds with hereditary nonpolyposis colorectal carcinoma (HNPCC), in whom hereditary MSI colon cancers develop. However, mice bearing null hPMS2 genes do not develop colon cancers and hPMS2 mutations in sporadic human colon cancers have not been described. Here we report that in Vaco481 colon cancer the hPMS2 gene is inactivated by somatic mutations of both hPMS2 alleles. The cell line derived from this tumor is functionally deficient in DNA mismatch repair. This deficiency can be biochemically complemented by addition of a purified hMLH1 -hPMS2 (hMutLalpha) complex. The hPMS2 deficient Vaco481 cancer cell line demonstrates microsatellite instability, an elevated HPRT gene mutation rate, and resistance to the cytotoxicity of the alkylator MNNG. We conclude that somatic inactivation of hPMS2 can play a role in development of sporadic MSI colon cancer expressing the full range of cancer phenotypes associated with inactivation microsatellite instability mutation of hPMS2 as a possible cause of sporadic human colon cancer with microsatellite instability.
12534642
[ "In", "114", "samples,", "the", "most", "frequent", "CYP1A2", "SNPs", "CYP1A2*1F", "),", "63C-->G", "(CYP1A2*2),", "and", "1545T-->C", "(alleles", "CYP1A2*1B,", "*1G,", "*1H", "and", "*3),", "using", "polymerase", "chain", "reaction-restriction", "fragment", "length", "polymorphism", "assays.", "All", "patients", "and", "controls", "were", "phenotyped", "for", "CYP1A2", "by", "h.p.l.c.", "analysis", "of", "urinary", "caffeine", "metabolites." ]
[ 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
In 114 samples, the most frequent CYP1A2 SNPs CYP1A2*1F ), 63C-->G (CYP1A2*2), and 1545T-->C (alleles CYP1A2*1B, *1G, *1H and *3), using polymerase chain reaction-restriction fragment length polymorphism assays. All patients and controls were phenotyped for CYP1A2 by h.p.l.c. analysis of urinary caffeine metabolites.
20646601
[ "Of", "208", "cases,", "91", "cases", "of", "K-ras", "gene", "mutation", "were", "detected.", "The", "12", " ", "or", "13", "mutation", "mutation", " ", "status", "and", "clinicopathological", "characteristics", "in", "colorectal", "cancer", "so", "as", "to", "select", "the", "patients", "likely", "to", "benefit", "from", "a", "targeted", "therapy." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 0, 0, 7, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Of 208 cases, 91 cases of K-ras gene mutation were detected. The 12 or 13 mutation mutation status and clinicopathological characteristics in colorectal cancer so as to select the patients likely to benefit from a targeted therapy.
22899730
[ "We", "evaluated", "the", "association", "between", "the", "BRAF", "c.1799T>A", "mutations", " ", "in", "colorectal", "cancer", "(CRC)", "are", "disproportionately", "observed", "in", "tumors", "exhibiting", "microsatellite", "instability", "(MSI)", "and", "are", "associated", "with", "other", "prognostic", "factors.", "The", "independent", "association", "between", "BRAF", "mutation", "status", "and", "CRC", "survival,", "however,", "remains", "unclear." ]
[ 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
We evaluated the association between the BRAF c.1799T>A mutations in colorectal cancer (CRC) are disproportionately observed in tumors exhibiting microsatellite instability (MSI) and are associated with other prognostic factors. The independent association between BRAF mutation status and CRC survival, however, remains unclear.
23096495
[ "Protein", "tyrosine", "phosphatase", "receptor-like", "genes", "are", "frequently", "hypermethylated", "in", "sporadic", "colorectal", "cancer." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer.